Related Experiment Videos
[Clinical study on cefteram pivoxil in pediatric field]
M Fujita1, T Kanda, E Nagayama
1Department of Pediatrics, Kanto Teishin Hospital.
The Japanese Journal of Antibiotics
|August 1, 1989
Summary
Cefteram pivoxil (CFTM-PI) demonstrated excellent or good clinical efficacy in pediatric patients with acute infections. This antibiotic showed comparable pharmacokinetic parameters to adults and no adverse reactions were observed in the study.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Clinical Microbiology
Context:
- Acute infectious diseases are common in pediatric populations.
- Effective and safe antibiotic options are crucial for treating pediatric infections.
- Understanding drug pharmacokinetics and efficacy in children is essential for therapeutic success.
Purpose:
- To evaluate the pharmacokinetic parameters of Cefteram pivoxil (CFTM-PI) in pediatric patients.
- To assess the clinical efficacy of CFTM-PI in children diagnosed with various acute infectious diseases.
- To monitor for any adverse reactions associated with CFTM-PI treatment in pediatric subjects.
Summary:
- Pharmacokinetic parameters of CFTM-PI in one pediatric patient were comparable to adult data.
- Clinical efficacy was evaluated in 16 children with acute urinary tract infections, respiratory infections, sinusitis, otitis media, and cervical lymphadenitis.
- Treatment responses were excellent in 43.8% and good in 56.3% of the pediatric patients, with no adverse reactions reported.
Impact:
- CFTM-PI shows promise as a safe and effective treatment option for acute infections in children.
- The findings support the use of CFTM-PI in pediatric infectious disease management.
- Further research may confirm these findings in larger pediatric cohorts.